Invest in a modern healthcare network by purchasing an equity stake. Currently with a new source of revenue-from clinical trials
The Váš lekár healthcare network, which includes a polyclinic in Eurovea, pharmacies, and outpatient clinics across the regions, has entered the high-margin segment of clinical drug trials. It thus combines stable outpatient care with access to state-of-the-art treatment and, at the same time, one of the fastest-growing sources of revenue in medicine.
With a single investment, you gain access to 4 healthcare segments—just like Dr. Boris Bajer, co-owner and medical guarantor of the Váš Lekár clinic. As part of the current funding round, you can co-own the group alongside other investors and participate in its future sale.
The health center’s strong foundation is complemented by a key growth driver: Phase III clinical trials for Pfizer-Metser. This involves testing the latest generation of an innovative drug for obesity and diabetes with the aim of surpassing current treatments.
The clinic is one of a select few centers in Slovakia and Europe, with a trained team, international expertise, and full certification. For investors, this represents a unique opportunity to co-own healthcare infrastructure with high-margin growth potential.
The expected return on investment is 2,5 to 4 times the initial investment over a 4 to 7 year period. The capital will be used to fund the operation of the health center.
Investment parameters
Parameter | Detail |
|---|---|
Type of investment | Purchase of equity shares – you become a co-owner of Váš Lekár |
Investor stake | Up to 3 % (the special-purpose company’s total stake will be 33 %) |
Use of capital | Funding for operations and the launch of clinical trials |
Investment horizon | ~4–7 years; option to sell the investment earlier through secondary trading |
Final evaluation | 20 %+ p.a. |
Return for the investor | Shareholder benefits, proceeds from the sale of the group / exit |
Exit strategy | Crowdberry secondary market; sale of the Group or a part thereof |
Investment protection | Liquidity preference (priority) equal to 1,5x the investment amount |
Why invest?
Clinical studies
The Váš Lekár group portfolio
Risks
Investing involves the risk of partial or total loss of the invested funds. The investment opportunity in the target company is provided by Crowdberry Investment Platform, s.r.o.
